Anhydrous Enol-oxaloacetate

N/A

Report date: 2025/10/23 20:00:06
NME

Base Information

Drug NameAnhydrous Enol-oxaloacetate
Drug Alias NameAEO
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayo ClinicNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMayo Clinic
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A